Trial Profile
Post-Marketing Study of Mirabegron - A Pharmacokinetic Study to Assess Drug-Drug Interaction Between Mirabegron and Tolterodine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary) ; Tolterodine
- Indications Nocturia; Overactive bladder
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 25 Oct 2013 New trial record